Published on in Vol 21, No 6 (2019): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14165, first published .
The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants’ Perceptions

The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants’ Perceptions

The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants’ Perceptions

Journals

  1. Del Hoyo J, Nos P, Faubel R, Bastida G, Muñoz D, Valero-Pérez E, Garrido-Marín A, Bella P, Peña B, Savini C, Aguas M. Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups. International Journal of Environmental Research and Public Health 2020;17(6):1871 View
  2. Zand A, Nguyen A, Stokes Z, van Deen W, Reynolds C, Dimitrova M, Khandadash A, Dvorsky M, Sauk J, Esrailian E, Hommes D. The Development of a Screening Tool to Identify and Classify Nonadherence in Inflammatory Bowel Disease. Crohn's & Colitis 360 2019;1(3) View
  3. Beard J, Franco D, Click B. The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care. Current Gastroenterology Reports 2020;22(2) View
  4. George L, Cross R. Remote Monitoring and Telemedicine in IBD: Are We There Yet?. Current Gastroenterology Reports 2020;22(3) View
  5. Yin A, Hachuel D, Pollak J, Scherl E, Estrin D. Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review. Journal of Medical Internet Research 2019;21(8):e14630 View
  6. Kennedy N, Hansen R, Younge L, Mawdsley J, Beattie R, Din S, Lamb C, Smith P, Selinger C, Limdi J, Iqbal T, Lobo A, Cooney R, Brain O, Gaya D, Murray C, Pollok R, Kent A, Raine T, Bhala N, Lindsay J, Irving P, Lees C, Sebastian S. Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic. Frontline Gastroenterology 2020;11(5):343 View
  7. Davis S, Ross M, Adatorwovor R, Wei H. Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review. Research in Nursing & Health 2021;44(1):155 View
  8. Bonnaud G, Haennig A, Altwegg R, Caron B, Boivineau L, Zallot C, Gilleta de Saint-Joseph C, Moreau J, Gonzalez F, Reynaud D, Faure P, Aygalenq P, Combis J, Peyrin-Biroulet L. Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2021;56(5):530 View
  9. Ghafari-Saravi A, Rabizadeh S, Dubovsky A, Miller S, Melmed G, van Deen W. Technical Issues Are a Major Determinant of Patient Satisfaction in Virtual Visits for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2021;27(12):2034 View
  10. Casellas F, González-Lama Y, Ginard Vicens D, García-López S, Muñoz F, Marín Sánchez L, Camacho L, Cabez A, Fortes P, Gómez S, Bella Castillo P, Barreiro-de Acosta M. Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document. Revista Española de Enfermedades Digestivas 2021 View
  11. Axelrad J, Long M, Horst S, Afzali A, Sapir T, Fajardo K, De Felice K, Sandler R, Cross R. A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2022;11(12):e40382 View
  12. Mostafaei A, Sadeghi-Ghyassi F, Kabiri N, Hajebrahimi S. Experiences of patients and providers while using telemedicine in cancer care during COVID-19 pandemic: a systematic review and meta-synthesis of qualitative literature. Supportive Care in Cancer 2022;30(12):10483 View
  13. Sachar Y, Gill J, Chande N. Impact of inflammatory bowel disease on student experience in postsecondary education. Journal of American College Health 2024;72(1):203 View
  14. Anvari S, Neumark S, Jangra R, Sandre A, Pasumarthi K, Xenodemetropoulos T. Best Practices for the Provision of Virtual Care: A Systematic Review of Current Guidelines. Telemedicine and e-Health 2023;29(1):3 View
  15. Majidova K, Handfield J, Kafi K, Martin R, Kubinski R. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes 2021;12(10):1465 View
  16. Yao J, Fekadu G, Jiang X, You J, Pittet V. Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic—A cost-effectiveness analysis. PLOS ONE 2022;17(4):e0266464 View
  17. Vinay G. Increased Self-medication with Steroids in Inflammatory Bowel Disease Patients during COVID-19 Pandemic: Time to Optimize Specialized Telemonitoring Services. Euroasian Journal of Hepato-Gastroenterology 2021;11(2):103 View
  18. Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, Bracewell K, Akobeng A. Remote care through telehealth for people with inflammatory bowel disease. Cochrane Database of Systematic Reviews 2023;2023(5) View
  19. Takahashi M, Nunotani M, Aoyama N. Construction of an Explanatory Model for Quality of Life in Outpatients with Ulcerative Colitis. Inflammatory Intestinal Diseases 2023;8(1):23 View
  20. Fantini M, Loddo E, Di Petrillo A, Onali S. Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review. Digestive and Liver Disease 2024;56(1):1 View
  21. Gu Z, Gu J, Liu P. The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic review. BMC Gastroenterology 2024;24(1) View